Publications by authors named "Valery Moine"

Claim this Profile
T
Tumor-dependent myeloid and lymphoid cell recruitment in genO-BRGSF-HIS mice: a novel tool for evaluating immunotherapies.
Gaëlle H Martin, Siham Hedir, Florent Creusat, Alexis Gonon, Amélie Marguier, Valery Moine

Front Immunol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NI-3201 Is a Bispecific Antibody Mediating PD-L1-Dependent CD28 Co-stimulation on T Cells for Enhanced Tumor Control.
Sara Majocchi, Pauline Lloveras, Lise Nouveau, Margaux Legrand, Alizee Viandier, Valéry Moine

Cancer Immunol Res· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting CEACAM5-positive solid tumors using NILK-2401, a novel CEACAM5xCD47 κλ bispecific antibody.
Anja Seckinger, Vanessa Buatois, Valéry Moine, Bruno Daubeuf, Françoise Richard

Front Immunol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and characterization of NILK-2301, a novel CEACAM5xCD3 κλ bispecific antibody for immunotherapy of CEACAM5-expressing cancers.
Anja Seckinger, Sara Majocchi, Valéry Moine, Lise Nouveau, Hoang Ngoc

J Hematol Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD47xCD19 bispecific antibody triggers recruitment and activation of innate immune effector cells in a B-cell lymphoma xenograft model.
Xavier Chauchet, Laura Cons, Laurence Chatel, Bruno Daubeuf, Gérard Didelot, Valéry Moine

Exp Hematol Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting a membrane-proximal epitope on mesothelin increases the tumoricidal activity of a bispecific antibody blocking CD47 on mesothelin-positive tumors.
Eric Hatterer, Xavier Chauchet, Françoise Richard, Leticia Barba, Valéry Moine

MAbs· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-Directed Blockade of CD47 with Bispecific Antibodies Induces Adaptive Antitumor Immunity.
Elie Dheilly, Stefano Majocchi, Valéry Moine, Gérard Didelot, Lucile Broyer

Antibodies (Basel)· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective Blockade of the Ubiquitous Checkpoint Receptor CD47 Is Enabled by Dual-Targeting Bispecific Antibodies.
Elie Dheilly, Valéry Moine, Lucile Broyer, Susana Salgado-Pires, Zoë Johnson

Mol Ther· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploiting light chains for the scalable generation and platform purification of native human bispecific IgG.
Nicolas Fischer, Greg Elson, Giovanni Magistrelli, Elie Dheilly, Nicolas Fouque, Valery Moine

Nat Commun· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid, simple and high yield production of recombinant proteins in mammalian cells using a versatile episomal system.
Giovanni Magistrelli, Pauline Malinge, Rami Lissilaa, Séverine Fagète, Florence Guilhot, Valéry Moine

Protein Expr Purif· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis